scholarly journals Pancoast Tumor as the Initial Presentation of a Metastatic Colon Adenocarcinoma

Cureus ◽  
2021 ◽  
Author(s):  
Ana Cunha ◽  
Miguel Quintela ◽  
Cláudia Costa ◽  
Armin A Quispe-Cornejo ◽  
Margarida Freitas-Silva
Keyword(s):  
Colon Adenocarcinoma ◽  
Initial Presentation ◽  
Pancoast Tumor

Myasthenic symptoms: From initial presentation to diagnosis

2012 ◽  
Vol 43 (02) ◽  
Author(s):  
H Trippe ◽  
M Munteanu ◽  
F Stehling ◽  
U Mellies ◽  
R Heller ◽  
...  
Keyword(s):  
Initial Presentation

In Vitro and in Vivo Comparison of Binding of 99m-Tc-Iabeled Anti-CEA MAb F33-104 with 99m-Tc-labeled Anti-CEA MAb BW431/26

1999 ◽  
Vol 38 (04) ◽  
pp. 115-119
Author(s):  
N. Oriuchi ◽  
S. Sugiyama ◽  
M. Kuroki ◽  
Y. Matsuoka ◽  
S. Tanada ◽  
...  
Keyword(s):  
Nude Mice ◽  
Binding Capacity ◽  
Colon Adenocarcinoma ◽  
Human Colon ◽  
Cell Binding ◽  
Vitro Binding ◽  
Labeling Method ◽  
Human Colon Adenocarcinoma

Summary Aim: The purpose of this study was to assess the potential for radioimmunodetection (RAID) of murine anti-carcinoembryonic antigen (CEA) monoclonal antibody (MAb) F33-104 labeled with technetium-99m (99m-Tc) by a reduction-mediated labeling method. Methods: The binding capacity of 99m-Tc-labeled anti-CEA MAb F33-104 with CEA by means of in vitro procedures such as immunoradiometric assay and cell binding assay and the biodistribution of 99m-Tc-labeled anti-CEA MAb F33-104 in normal nude mice and nude mice bearing human colon adenocarcinoma LS180 tumor were investigated and compared with 99m-Tc-labeled anti-CEA MAb BW431/26. Results: The in vitro binding rate of 99m-Tc-labeled anti-CEA MAb F33-104 with CEA in solution and attached to the cell membrane was significantly higher than 99m-Tclabeled anti-CEA MAb BW431/261 (31.4 ± 0.95% vs. 11.9 ± 0.55% at 100 ng/mL of soluble CEA, 83.5 ± 2.84% vs. 54.0 ± 2.54% at 107 of LS 180 cells). In vivo, accumulation of 99m-Tc-labeled anti-CEA MAb F33-104 was higher at 18 h postinjection than 99m-Tc-labeled anti-CEA MAb BW431/26 (20.1 ± 3.50% ID/g vs. 14.4 ± 3.30% ID/g). 99m-Tcactivity in the kidneys of nude mice bearing tumor was higher at 18 h postinjection than at 3 h (12.8 ± 2.10% ID/g vs. 8.01 ± 2.40% ID/g of 99m-Tc-labeled anti-CEA MAb F33-104, 10.7 ± 1.70% ID/g vs. 8.10 ± 1.75% ID/g of 99m-Tc-labeled anti-CEA MAb BW431/26). Conclusion: 99m-Tc-labeled anti-CEA MAb F33-104 is a potential novel agent for RAID of recurrent colorectal cancer.

Ulnaris-Operation und Botulinumtoxintherapie bei Pancoast-Tumor

2006 ◽  
Vol 33 (S 1) ◽  
Author(s):  
O. Gregor ◽  
S. Dettmann ◽  
J.J. Schwarze ◽  
J. Klingelhöfer
Keyword(s):  
Pancoast Tumor
Sign in / Sign up

Export Citation Format

Share Document